APIMEDS PHARMACEUTICALS US, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
APIMEDS PHARMACEUTICALS US, INC. (APUS) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$1.26 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-05-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-05-04
- APIMEDS PHARMACEUTICALS US, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$1.26M.
- APIMEDS PHARMACEUTICALS US, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$291.90K.
- APIMEDS PHARMACEUTICALS US, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$163.31K.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$1.26M 10-K · filed 2026-05-04 | |
| 2024-12-31 | -$291.90K 10-K · filed 2026-05-04 | -$291.90K 10-K · filed 2025-04-15 |
| 2023-12-31 | -$163.31K 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |